News
A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.
In the first part of this series, we explored how early genetic screening and gene therapy transform the lives of newborns ...
The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...
Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...
As newborn screening and rapid DNA sequencing become routine, we are poised to catch and treat inherited diseases at their ...
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...
New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...
After spending over 300 days at CHOP, KJ Muldoon has been released from the hospital after receiving personalized CRISPR gene ...
KJ Muldoon, a 10-month-old baby, was diagnosed with the genetic disease carbamoyl-phosphate synthetase 1 deficiency after he ...
After spending over 300 days at CHOP, KJ Muldoon has been released from the hospital after receiving personalized CRISPR gene ...
The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results